Pharmacotherapy

Published results showed patients with obesity who took anti-obesity medications and had postoperative weight loss within 1 year after total joint arthroplasty may be at significantly decreased risk for revision at 5 and 10 years.

Adolescents in the United States with symptoms of ADHD had a higher likelihood of using tobacco and other nicotine-based products, results from a cohort study published in JAMA Network Open showed.

Unintentional weight loss prior to kidney transplant evaluation may be linked to lower listing odds and higher waitlist mortality for frail patients with obesity, a study found.

Entering 2025, adults with moderate to severe obstructive sleep apnea and obesity have a new FDA-approved treatment option that takes the form of a GIP/GLP-1 dual agonist, according to a press release from Eli Lilly and Company.

Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults undergoing screening for lung cancer, the results of a randomized clinical trial showed.

Individuals with pancreatic cancer underutilized palliative care and mental health services, according to a retrospective analysis.

SAN ANTONIO — In this Healio video exclusive, Jamy D. Ard, MD, FTOS, provided a 1-year update on The Obesity Society’s multisociety initiative to develop Standards of Care for obesity.

PHILADELPHIA — Pharmacologic therapy for alcohol use disorder may be an “underutilized treatment modality,” especially in patients with related liver disease, according to research presented at the ACG Annual Scientific Meeting.

SAN ANTONIO — In adolescents with obesity, GLP-1 receptor agonists were associated with lower risk for incident hypertension development 5 and 10 years after initiation vs. other anti-obesity medications, a speaker reported.

Smoking cessation within 6 months of a cancer diagnosis can significantly improve survival, according to results of a prospective study.